Correction: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia

• Heba Shawky,
• Ashraf A. Tabll,
• Reem M. Elshenawy,
• Naiera M. Helmy,
• Rehab I. Moustafa,
• Yasser K. Elesnawy,
• Marwa M. Abdelghany,
• Yasmine S. El-Abd

Affiliations

Heba Shawky

Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre

Ashraf A. Tabll

Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre

Reem M. Elshenawy

Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre

Naiera M. Helmy

Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre

Rehab I. Moustafa

Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre

Yasser K. Elesnawy

National Committee for Control of Viral Hepatitis (NCCVH), Ministry of Health and Population

Marwa M. Abdelghany

Ahmed Maher Teaching Hospital

Yasmine S. El-Abd

Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre